City
Epaper

Vitamin D may not protect from Covid infection or severity

By IANS | Updated: June 2, 2021 16:00 IST

Toronto, June 2 Genetic evidence does not support vitamin D as a protective measure against Covid-19, say researchers....

Open in App

Toronto, June 2 Genetic evidence does not support vitamin D as a protective measure against Covid-19, say researchers.

The team from McGill University in Quebec, Canada, analyzed genetic variants of 4,134 individuals with Covid-19, and 1,284,876 without Covid-19, from 11 countries to determine whether genetic predisposition for higher vitamin D levels were associated with less-severe disease outcomes in people with Covid-19.

The results, published in PLOS Medicine, showed no evidence for an association between genetically predicted vitamin D levels and Covid-19 susceptibility, hospitalisation, or severe disease. This suggests that raising circulating vitamin D levels through supplementation may not improve Covid-19 outcomes in the general population.

Increased vitamin D levels, as reflected by 25-hydroxy vitamin D measurements, have been proposed to protect against Covid-19 based on in vitro, observational, and ecological studies.

But, "Vitamin D supplementation as a public health measure to improve outcomes is not supported by this study," said researchers including Guillaume Butler-Laporte and Tomoko Nakanishi from the varsity.

However, the team noted several limitations, including that the research did not include individuals with vitamin D deficiency, and it remains possible that truly deficient patients may benefit from supplementation for Covid-19 related protection and outcomes.

Additionally, the genetic variants were obtained only from individuals of European ancestry, so future studies will be needed to determine the relationship with Covid-19 outcomes in other populations.

A previous study also showed similar results. Scientists from the University of Sao Paulo conducted a clinical trial in Brazil with 240 patients who were given 200,000 IU of vitamin D3 on admission to hospital.

The supplementation did not reduce length of stay or affect the proportion requiring intensive care, according to the study published in the Journal of the American Medical Association (JAMA).

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Institute of Economic Research FoundationtorontocanadaMcgill UniversityCity of torontoMcgillIndia canadaMcgill university in canada
Open in App

Related Stories

MumbaiMumbai Police Visit Kapil Sharma’s Residence After Firing at His Kap’s Café in Canada

NationalKap's Cafe Pens Emotional Message After Gunfire Attack: ‘Processing This Shock, But Not Giving Up’

EntertainmentFiring at Kapil Sharma’s Newly Opened Kaps Cafe in Canada; Khalistani Group Claims Responsibility

OpinionsVicious Plot to Drown Nation in Drugs

LifestyleSending Rakhi to Canada? Here’s How to Make It Extra Memorable

Health Realted Stories

HealthLifestyle solution might yield better results for Indians with obesity risk, says study

Health48 projects approved to avoid disruption in supply of critical active pharma ingredients

HealthDrugs and pharmaceuticals export up 92 pc in last 6 fiscals: Minister

Health1,77,906 Ayushman Arogya Mandirs established under AB PM-JAY till June: Centre

Health126 specialist doctors in Jharkhand receive appointments through bidding process, Minister hands over letters